Literature DB >> 31546023

Regulation of F-box proteins by noncoding RNAs in human cancers.

Min Lin1, Yichi Xu1, Ying Gao1, Chunyu Pan1, Xueqiong Zhu2, Zhi-Wei Wang3.   

Abstract

F-box proteins (FBPs) are proteins containing an F-box domain and are one of three subunits in SKP1-Cullin1-F-box protein (SCF) E3 ligase complexes. Accumulated evidence has shown that FBP regulates tumorigenesis and the progression of human cancer via ubiquitination and degradation of downstream substrates, which can be oncoproteins or tumor suppressors. Emerging evidence has revealed that noncoding RNAs (ncRNAs) govern the expression of FBP in human cancers. Specifically, microRNAs (miRNAs), long ncRNAs (lncRNAs), and circular RNAs (circRNAs) have been shown to govern FBP expression in malignancies. Therefore, in this review article, we discuss how miRNAs target FBPs and participate in tumorigenesis and tumor progression. Moreover, we briefly highlight the role of lncRNAs and circRNAs in the regulation of FBPs in cancer. Therefore, targeting ncRNAs could be a novel approach to regulate FBPs for anticancer therapy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FBXW7; MiRNA; Skp2; Ubiquitination; β-TrCP

Mesh:

Substances:

Year:  2019        PMID: 31546023     DOI: 10.1016/j.canlet.2019.09.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

Review 1.  The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer.

Authors:  Yi Liu; Hejing Liu; Bo Sheng; Shuya Pan; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Apoptosis       Date:  2022-08-18       Impact factor: 5.561

2.  Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation.

Authors:  Qi Wang; Linhui Wu; Ruoxue Cao; Jing Gao; Damin Chai; Yanzi Qin; Li Ma; Shiwu Wu; Yisheng Tao; Jia Ma; Zhi-Wei Wang
Journal:  Oncogene       Date:  2022-09-20       Impact factor: 8.756

3.  CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma.

Authors:  Tong Cao; Yue Cui; Yingying Wang; Linhui Wu; Ke Yu; Kai Chen; Jun Xia; Yuyun Li; Zhiwei Peter Wang; Jia Ma
Journal:  Apoptosis       Date:  2022-08-29       Impact factor: 5.561

Review 4.  The role of Fbxo5 in the development of human malignant tumors.

Authors:  Junjie Gao; Dandan Yang; Ruoxue Cao; Hua Huang; Jia Ma; Zhiwei Wang; Jun Xia; Xueshan Pan
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

Review 5.  Diverse Roles of F-BoxProtein3 in Regulation of Various Cellular Functions.

Authors:  Zhiyang Zhang; Zhengqi Bao; Penglian Gao; Junyi Yao; Peter Wang; Damin Chai
Journal:  Front Cell Dev Biol       Date:  2022-01-19

6.  Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm.

Authors:  Siteng Chen; Encheng Zhang; Liren Jiang; Tao Wang; Tuanjie Guo; Feng Gao; Ning Zhang; Xiang Wang; Junhua Zheng
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

Review 7.  Clinical significance of FBXW7 loss of function in human cancers.

Authors:  Jingyi Fan; Marcia Bellon; Mingyi Ju; Lin Zhao; Minjie Wei; Liwu Fu; Christophe Nicot
Journal:  Mol Cancer       Date:  2022-03-26       Impact factor: 27.401

Review 8.  The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression.

Authors:  Lu Xia; Jingyun Chen; Min Huang; Jie Mei; Min Lin
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

9.  LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion.

Authors:  Rong Li; Zhen Chen; Yubo Zhou; Gulikezi Maimaitirexiati; Qi Yan; Yuting Li; Adilijiang Maimaitiyimin; Changhui Zhou; Jingqin Ren; Chengqing Liu; Abasi Mainike; Peng Zhou; Lu Ding
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

Review 10.  FBXO45 is a potential therapeutic target for cancer therapy.

Authors:  Min Lin; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Cell Death Discov       Date:  2020-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.